Comment on: Failure to use new breakthrough treatments for epilepsy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comment on: Failure to use new breakthrough treatments for epilepsy

Published:2023-09-05 Issue:11 Volume:64 Page:3109-3110
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Peters Jurriaan M.¹^ORCID,Becker Danielle A.²^ORCID,Verma Amit³,Sirven Joseph⁴

Affiliation:

1. Harvard Medical School and Boston Children's Hospital Boston Massachusetts USA

2. Department of Neurology Case Western Reserve University School of Medicine Cleveland Ohio USA

3. Stanley H. Appel Department of Neurology, Houston Methodist Hospital Houston Texas USA

4. Department of Neurology Mayo Clinic Jacksonville Florida USA

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.17764

Reference11 articles.

1. Failure to use new breakthrough treatments for epilepsy

2. It Takes an Average of 17 Years for Evidence to Change Practice—the Burgeoning Field of Implementation Science Seeks to Speed Things Up

3. Burden of Seizure Clusters on Patients With Epilepsy and Caregivers

4. Written seizure action plans for adult patients with epilepsy: Distilling insights from emergency action plans for other chronic conditions

5. The ‘vicious cycle’ of personalised asthma action plan implementation in primary care: a qualitative study of patients and health professionals’ views

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP